Electroclinical Improvement in a Patient with Ring Chromosome 20 Syndrome Treated with Zonisamide: A Case Report.

J Pediatr Genet

Department of Child Neurology and Psychiatry, IRCSS Mondino Foundation, European Reference Network for Rare and Complex Epilepsies, EpiCARE, Pavia, Italy.

Published: September 2023

Ring chromosome 20 or r(20) syndrome is a rare chromosomal disorder, mainly characterized by childhood-onset drug-resistant epilepsy with typical electroencephalographic findings, followed by mild to severe cognitive-behavioral decline. Recent studies support a possible role of the dopaminergic system in the epileptogenesis of this syndrome. We report the case of a 13-year-old female with mosaic r(20) who showed typical disease onset and evolution and a remarkable electroclinical improvement with zonisamide. Epilepsy related to r(20) is often medically intractable. When valproate and lamotrigine are not effective, zonisamide could be further investigated as a therapeutic option, since it acts as antifocal and it has a potential role in the prevention of dopamine depletion.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421690PMC
http://dx.doi.org/10.1055/s-0041-1726281DOI Listing

Publication Analysis

Top Keywords

electroclinical improvement
8
ring chromosome
8
improvement patient
4
patient ring
4
chromosome syndrome
4
syndrome treated
4
treated zonisamide
4
zonisamide case
4
case report
4
report ring
4

Similar Publications

Efficacy and tolerability of celastrol and edaravone in the multiple-hit rat model of infantile spasms.

Epilepsy Behav

January 2025

Albert Einstein College of Medicine, Saul R. Korey Department of Neurology, Laboratory of Developmental Epilepsy, Albert Bronx, NY, USA; Isabelle Rapin Division of Child Neurology, Albert Einstein College of Medicine, Bronx, NY, USA; Dominick P Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address:

Objective: To test whether anti-inflammatory and antioxidant drugs that inhibit the nuclear factor kappa light chain enhancer of activated B cells (NF-kB), celastrol and edaravone, suppress spasms and improve developmental outcomes in the multiple-hit rat model of refractory infantile spasms (IS) due to structural lesions.

Methods: Postnatal day 3 (PN3) Sprague-Dawley rats were treated according to the multiple-hit IS model protocol. Using a randomized, blinded, vehicle-controlled, dose- and time-response study design, we tested the effects of single celastrol [1, 2, or 4 mg/kg intraperitoneally (i.

View Article and Find Full Text PDF
Article Synopsis
  • Continuous EEG monitoring (cEEG) allows for the tracking of EEG patterns in patients with acute brain injuries, but detailed trends during this phase have not been thoroughly studied.
  • A retrospective review of 101 patients who underwent cEEG highlighted a significant percentage showing improvement or resolution of epileptic EEG findings by discharge, although certain patterns like lateralized periodic discharges persisted or worsened.
  • The findings suggest a general trend towards normalization of most epileptiform patterns over time, indicating a need for further exploration of their clinical implications regarding treatment and patient outcomes.
View Article and Find Full Text PDF

In medication-resistant epilepsy, the goal of epilepsy surgery is to make a patient seizure free with a resection/ablation that is as small as possible to minimize morbidity. The standard of care in planning the margins of epilepsy surgery involves electroclinical delineation of the seizure-onset zone and incorporation of neuroimaging findings from MRI, PET, single-photon emission CT and magnetoencephalography modalities. Resecting cortical tissue generating high-frequency oscillations has been investigated as a more efficacious alternative to targeting the seizure-onset zone.

View Article and Find Full Text PDF
Article Synopsis
  • This study aimed to compare levels of specific interleukins (IL-6, IL-8, IL-10) in children with different types of epilepsy: Epileptic encephalopathy with spike-wave activation in sleep (EE-SWAS), drug refractory epilepsy (DRE), and well-controlled epilepsy (WCE).
  • Researchers followed children with EE-SWAS who received a three-month steroid treatment alongside their ongoing seizure medications and evaluated their cognitive and behavioral responses.
  • Results showed that IL-6 and IL-8 levels were significantly higher in the EE-SWAS group compared to the others, and a decrease in IL-6 levels after one month was associated with better clinical outcomes at three months.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!